Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
News-Medical.Net on MSN
Novel antisense oligonucleotide shows promise against aggressive pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
Explore how aggressive breast cancer evades immune defences and discover potential treatment strategies with our latest ...
GlobalData on MSN
MSD begins KANDLELIT-007 trial of calderasib for NSCLC
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...
The Krainer lab discovered a three-oncogene circuit that helps drive the aggressive progression of pancreatic ductal ...
News Medical on MSN
Breast cancer hijacks immune alarm: turning defense into cancer-fueling inflammation
With a new study in the journal Science Bulletin, researchers at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University have ...
Pancreatic ductal adenocarcinoma (PDAC) is both the most common and the deadliest type of pancreatic cancer. Most treatment ...
An international team of scientists has analyzed the ongoing colonization by two retroviruses of the germline of koalas and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results